Providence Capital Advisors, LLC Novartis Ag Transaction History

Providence Capital Advisors, LLC

$487 Million
Q3 2024

A detailed history of Providence Capital Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Providence Capital Advisors, LLC holds 28,913 shares of NVS stock, worth $3.02 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

28,913

Previous 35,533 18.63%

Holding current value

$3.02 Million

Previous $3.78 Million 12.08%

% of portfolio

0.68%

Previous 0.85%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $702,580 - $800,291	-6,620 Reduced 18.63%	28,913 $3.33 Million
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $38,509 - $44,665	416 Added 1.18%	35,533 $3.78 Million
Q1 2024 May 13, 2024	SELL	$95.27 - $108.47 $27,628 - $31,456	-290 Reduced 0.82%	35,117 $3.4 Million
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $18,282 - $20,290	193 Added 0.55%	35,407 $3.61 Million
Q2 2023 Aug 10, 2023	BUY	$92.52 - $104.91 $47,925 - $54,343	518 Added 1.49%	35,214 $3.55 Million
Q1 2023 May 17, 2023	SELL	$80.03 - $92.81 $253 Million - $293 Million	-3,157,417 Reduced 98.91%	34,696 $3.19 Million
Q1 2023 May 17, 2023	BUY	$80.03 - $92.81 $255 Million - $296 Million	3,191,705 Added 782280.62%	3,192,113 $294 Million
Q1 2023 May 10, 2023	SELL	$80.03 - $92.81 $2.7 Million - $3.13 Million	-33,700 Reduced 98.8%	408 $37,000
Q4 2022 Feb 07, 2023	SELL	$75.55 - $92.52 $151 - $185	-2 Reduced 0.01%	34,108 $3.09 Million
Q3 2022 Nov 09, 2022	BUY	$74.61 - $87.26 $52,077 - $60,907	698 Added 2.09%	34,110 $2.59 Million
Q2 2022 Aug 09, 2022	BUY	$80.52 - $93.75 $853,109 - $993,281	10,595 Added 46.43%	33,412 $2.82 Million
Q1 2022 May 12, 2022	BUY	$80.11 - $90.62 $147,001 - $166,287	1,835 Added 8.75%	22,817 $2 Million
Q4 2021 Feb 11, 2022	BUY	$79.7 - $88.13 $66,390 - $73,412	833 Added 4.13%	20,982 $1.84 Million
Q3 2021 Nov 09, 2021	BUY	$81.78 - $95.14 $151,865 - $176,674	1,857 Added 10.15%	20,149 $1.65 Million
Q2 2021 Aug 09, 2021	BUY	$85.24 - $94.15 $93,337 - $103,094	1,095 Added 6.37%	18,292 $1.67 Million
Q1 2021 May 13, 2021	BUY	$83.5 - $98.47 $31,062 - $36,630	372 Added 2.21%	17,197 $1.47 Million
Q4 2020 Feb 11, 2021	BUY	$78.07 - $94.43 $133,890 - $161,947	1,715 Added 11.35%	16,825 $1.59 Million
Q3 2020 Nov 13, 2020	BUY	$82.14 - $91.0 $40,084 - $44,408	488 Added 3.34%	15,110 $1.31 Million
Q2 2020 Aug 04, 2020	SELL	$80.93 - $91.1 $9,873 - $11,114	-122 Reduced 0.83%	14,622 $1.28 Million
Q1 2020 May 12, 2020	BUY	$70.67 - $99.01 $1.04 Million - $1.46 Million	14,744 New	14,744 $1.22 Million
Q1 2018 May 10, 2018	SELL	$70.39 - $84.15 $3,167 - $3,786	-45 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$72.33 - $77.64 $3,254 - $3,493	45	45 $4,000

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Capital Advisors, LLC with notifications on news.

Account

Providence Capital Advisors, LLC Novartis Ag Transaction History